Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer.

Authors:
Ng AY; Oberije CJG; Ambrózay É; Szabó E; Serfőző O and 6 more

Journal:
Nat Med

Publication Year: 2023

DOI:
10.1038/s41591-023-02625-9

PMCID:
PMC10719086

PMID:
37973948

Journal Information

Full Title: Nat Med

Abbreviation: Nat Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Evidence found in paper:

"the code provided at https://github com/kheiron-medical/mammo-net demonstrates the training and testing of state-of-the-art cnns that build the core component of most commercially available ai systems for breast cancer detection."

Evidence found in paper:

"Competing interests This postmarket analysis was funded by Kheiron Medical Technologies Ltd. (‘Kheiron’). C.J.G.O., E.K., A.Y.N., G. Fox, B.G. and P.D.K. are employees of Kheiron and hold stock options as part of the standard compensation package. E.A.M. holds an advisory board member position and stock options at Kheiron Medical Technologies. G. Forrai is a paid consultant for Kheiron Medical Technologies. É.A., E.S. and O.S. declare no competing interests."

Evidence found in paper:

"Annie Y. Ng, Cary J.G. Oberije and Éva Ambrózay contributed equally to this article and share first authorship. We thank MaMMa Egészségügyi Zrt. (MaMMa Klinika), Béker-Soft Informatika Kft., A. Vadászy, D. Visi, R. Kovács, C. Gadóczi, T. Rijken, J. Yearsley and S. Kerruish for supporting the collection of data and execution of the evaluation. Competing interests: This postmarket analysis was funded by Kheiron Medical Technologies Ltd. (‘Kheiron’). C.J.G.O., E.K., A.Y.N., G. Fox, B.G. and P.D.K. are employees of Kheiron and hold stock options as part of the standard compensation package. E.A.M. holds an advisory board member position and stock options at Kheiron Medical Technologies. G. Forrai is a paid consultant for Kheiron Medical Technologies. É.A., E.S. and O.S. declare no competing interests."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025